Data Driven Personalized Seizure Management
Always looking out for you
Our Story
EnlitenAI is a story of love and passion.
EnlitenAI is a founder’s tribute to his son whom he lost recently and for the millions of others who suffer from this dreadful ailment. His 20+yrs of life experiences in dealing with drug resistant epilepsy has been the key driving force behind EnlitenAI. The team decided to leverage their professional experiences in Computational Sciences and Digital technologies to build an AI platform to address unmet needs in the space of seizure management.
WE ARE DEVICE AGNOSTIC AND DATA HUNGRY!
AI Engine for Insightful Care
We gather real world evidence to create personalized insights leading to immense potential for data monetization
Our team
Our team is extremely passionate and highly driven. Our team comprises members with extensive experience in building Digital Platforms, leveraging Data Science/AI and a great understanding of regulatory compliance and clinical development.
Dr. Himanshu Misra
Chief Executive Officer/Founder
Digital Health Entrepreneur with deep domain knowledge in Seizure management and Computational Sciences/AI/HPC
Dr. Paul Garcia
Chief Medical Advisor
Professor at UCSF Neurology. Renowned Epileptologist focused on improving the diagnosis and treatment of people with hard-to-treat epilepsy.
Abhiroop Gandhi
Chief Operating Officer
Biopharma Business executive with extensive knowledge of risk management, global regulatory structure and clinical development
Sreeman Nanduri
Chief Technology Officer
Sreeman Nanduri is a results-driven Healthcare leader with progressive experience spanning product management, technology and strategy.
Dr. Wei Fan
Chief , Data Science
Dr Fan is a highly accomplished business executive and technologist with over 20yrs experience in AI, Data Analytics and Big Data R&D.
Testimonials By Industry Experts
"Data-driven artificial intelligence technologies have the potential to revolutionize the way seizure treatment is optimized. Faster antiepileptic medication titrations based on the management of clinical and subclinical information will lead to faster and better mitigation of drug-averse and common epilepsy"
Dr. Pauzaskie
It is very helpful that EnlitenAI is developing their solution with the full ecosystem in mind, the patient/caregiver, the Neurologist, and Pharma.
Ben Walker
Always looking out for you
- General enquiries
- info@enlitenai.com
- For job aspirants
- career@enlitenai.com
- For investment/partnership
- himanshu@enlitenai.com
- (408)483-1742
- Empowerment
Problems we solve
Uniqueness
Empowerment
- Our Product
Our Solution
Our Value Proposition
Neuroliten
Demo
Download Product
- Our Team
Leadership
Advisors
Term of Use
Privacy Policy
- Our Partners
List of All Partners
- Epilepsy Resources
Links
- Contact Us
Careers
Want to Partner?
© 2023 EnlitenAI, Inc. All rights reserved.